Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt. | 28 | - |
| 2 | Schedule 2 | SUNIL PHARMACY | 5 | ₹12,672 |
| 3 | Schedule 3 | PHARMA (INDIA) | 12 | ₹12,780 |
| 4 | Schedule 4 | PRAKASH MEDICOS | 2 | ₹48,840 |
| 5 | Schedule 5 | OM SHANTI MEDICOS | 13 | ₹7,488 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
6 Aug 2026, 12:00 pmClosed
VILDAGLIPTIN 50MG TAB
ZOLPIDEM 10 MG TAB
AMLODIPINE 2.5MG TAB
ATAZANAVIR 300MG AND RITONAVIR 100MG TAB
BACLOFEN 10MG TAB
BISOPPROLOL 5MG TAB
CARVEDILOL 12.5 MG TAB
9626596
GEM/2026/B/7804515
Two Packet Bid
VILDAGLIPTIN 50MG TAB,ZOLPIDEM 10 MG TAB,AMLODIPINE 2.5MG TAB,ATAZANAVIR 300MG AND RITONAVIR 100MG
Mumbai, Maharashtra
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹1 L
₹2 L
20%
Exempted
Yes
6 Aug 2026
27 Jul 2026
6 Aug 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | VILDAGLIPTIN 50MG TAB | 1,92,000 | No | Mumbai | 30 |
| 2 | ZOLPIDEM 10 MG TAB | 14,400 | No | Mumbai | 30 |
| 3 | AMLODIPINE 2.5MG TAB | 85,200 | No | Mumbai | 30 |
| 4 | ATAZANAVIR 300MG AND RITONAVIR 100MG TAB | 1,200 | No | Mumbai | 30 |
| 5 | BACLOFEN 10MG TAB | 19,200 | No | Mumbai | 30 |
| 6 | BISOPPROLOL 5MG TAB | 32,400 | No | Mumbai | 30 |
| 7 | CARVEDILOL 12.5 MG TAB | 24,000 | No | Mumbai | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9626596.pdf
GEM_BID • 0.14 MB
bbqr_echs__2026-07-18-11-43-49_9c6e421abac0ecc3bb7365e42e164870.pdf
BOQ • 0.36 MB
vildagliptin_2026-07-18-11-43-49_b8e27d19cfe25741daf662ce0ccc45ef.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .